-
-
Call more information
660-596-2224 -
Authors: Rodriguez-Patarroyo et al. Anesthesiology August 20, 2025. doi:10.1097/ALN.0000000000005730 SummaryIn a randomized cross-over study of 20 healthy volunteers, five full-body forced-air warming systems were compared. Across devices, heat flux flipped from net loss to net gain within 5 minutes, and mean skin temperature rose to ~35.5°C by 15 minutes, then stabilized. No statistically or clinically […]
Read MoreAuthor: Gomez M, et al. Journal of Neurosurgical Anesthesiology 37(3):271-278, July 2025. doi:10.1097/ANA.0000000000000981 This case series evaluated the effectiveness of epidural blood patch (EBP) in treating spontaneous intracranial hypotension (SIH). Data from 36 patients at a single Canadian center (2010–2022) were analyzed, encompassing 82 EBP procedures. Clinical details, treatment techniques, and outcomes were reviewed, with […]
Read MoreAuthor: Pierson D, et al. A & A Practice 19(7):e02017, July 2025. doi:10.1213/XAA.0000000000002017 This Continuous Quality Improvement (CQI) study compared preoperative anterior quadratus lumborum block (aQLB; bupivacaine + dexamethasone sodium phosphate + methylprednisolone acetate) with the surgeon-placed intraoperative transversus abdominis plane block (sTAP; bupivacaine + liposomal bupivacaine) within an ERAS pathway for DIEP free-flap breast […]
Read MoreAuthor: Sophie Eydis Becker’s ASC Review Anesthesia is one of the most emerging threats to ASC profitability. While supply costs, staffing shortages and payer negotiations often dominate executive discussions, anesthesia-related expenses and reimbursement challenges are eroding margins. Here are five things to know about the current state of anesthesiology as it pertains to ASCs: 1. […]
Read MoreAuthor: Ferraro M, et al. Cochrane Database of Systematic Reviews, August 17, 2025. This review examined 67 randomized controlled trials with more than 2300 adults evaluating ketamine, memantine, dextromethorphan, amantadine, and magnesium for chronic noncancer pain. Despite widespread off-label use, there was no convincing evidence that these NMDA receptor agonists reduced pain intensity across short, […]
Read More